S5 Ep32: Author, Cancer Survivor Channeled Her Grief Into a Series of Books
Cancer Horizons2 Nov 2023

S5 Ep32: Author, Cancer Survivor Channeled Her Grief Into a Series of Books

Charlene Wexler has turned profound grief into a world of stories.


Wexler is the Chicago-based author of seven books as well as several short stories. Inspiration for what would become her 2014 debut novel, “Lori,” arrived following the loss of her son, Jeffrey, who received a diagnosis of leukemia in 1977 at the age of eight and died in 1981 at the age of 12.


“I always wrote for myself, and writing fiction is a new career. I started about 10 years ago,” said Wexler, who is now 80 years old.


“Cancer has been in our family for years: aunts, uncles, my mother, my grandfather, I had ovarian cancer, right now I have skin cancer. And we've dealt with all of them,” she explained. “And the cancer that really knocked us out was when my 8-year-old son, my firstborn, was diagnosed with leukemia. And we fought at Children's Memorial (Hospital, now known as Ann and Robert H. Lurie Children's Hospital of Chicago). We dealt with that, we fought the cancer for four and a half years before he died.


“And during that whole time, I wrote, I kept journals. And then after he died, I was devastated and (I) really couldn't get out of bed.”


Then, Wexler started writing.


“I took all my stuff together that I had been writing about him, and I wrote a story,” she said. “And I sent it to my sister who reads anything I write, who was there for me the whole time. And she said, 'This is great, but it's too devastating.' She said, 'Why don't you try again? Nobody's going to want to read this. It's just too grief ridden.'”


More survivor stories: Former Opera Singer Shares Bone Cancer Journey in New Book


Wexler shifted her writing from the first-person to the third-person and moved from memoir into the realm of fiction.


“I found (that), my God, I could change it,” she said. “And instead of making him a boy, I made her a girl. And when I first started writing, I thought, 'I'm going to make her survive it.’ That (even though) Jeffrey didn't, I'm going to make Julie, the girl in my story, live. But then, as I started writing, I realized I wanted to add what happened to me and how I survived — and how I didn't survive in the beginning.


“And then, after I wrote the first draft, I realized the book needed more than just a child dying from leukemia. And all of a sudden, the character Lori became stronger than the child that died. And I felt like there are a lot of issues I can deal with. A third of the book deals with the cancer, and it deals with surviving afterwards.”


Also from the “Cancer Horizons” podcast: Mother with Stage 4 Breast Cancer and Her Family 'Focus on the Living'


For Wexler, a former teacher who also spent time working in her husband’s dental office, “Lori” became the start of the four-book Laughter and Tears series, and her work is currently being re-released via Speaking Volumes.


Wexler spoke with CURE®’s “Cancer Horizons” podcast about her cancer journeys, her path to becoming an author and the different challenges faced by patients and caregivers.


For more news on cancer updates, research and education, don’t forget to subscribe to CURE®’s newsletters here.







Denne episoden er hentet fra en åpen RSS-feed og er ikke publisert av Podme. Den kan derfor inneholde annonser.

Episoder(295)

S7 Ep2: Breaking Down Metastatic Triple-Negative Breast Cancer Treatments

S7 Ep2: Breaking Down Metastatic Triple-Negative Breast Cancer Treatments

CURE sat down with Dr. Natalie S. Berger for the latest episode of the “Cancer Horizons” podcast to discuss frontline treatment options for patients with metastatic triple-negative breast cancer. Berg...

31 Des 202514min

S7 Ep1: The Importance of Spotting Endometrial Cancer

S7 Ep1: The Importance of Spotting Endometrial Cancer

Endometrial cancer is on the rise. Hear survivor Angélica and Eisai Inc.'s Teresa Cronin discuss the Spot Her® initiative, which empowers women to spot early signs. This episode is sponsored by Eisai.

18 Mar 202510min

S6 Ep23: ROS1+ Non-Small Cell Lung Cancer: Progress in Care

S6 Ep23: ROS1+ Non-Small Cell Lung Cancer: Progress in Care

17 Sep 202419min

S6 Ep22: Oncology Approvals, Psychological Outcomes for Survivors and an Ovarian Cancer Vaccine

S6 Ep22: Oncology Approvals, Psychological Outcomes for Survivors and an Ovarian Cancer Vaccine

Last week we saw some FDA approvals come through, as well as research that explored the psychosocial outcomes of individuals who survived pediatric rhabdosarcoma. And finally, we’ll discuss another ca...

4 Mar 20247min

S6 Ep21: Cannabis Talks During Cancer, Cardiometabolic Comorbidities and Current Research

S6 Ep21: Cannabis Talks During Cancer, Cardiometabolic Comorbidities and Current Research

In addition to a breakthrough therapy designation for a lung cancer drug, this week we’ll be talking a lot about additional side effects and health conditions that may come with a cancer diagnosis, an...

4 Mar 202410min

S6 Ep20: FDA Approvals from February 2024

S6 Ep20: FDA Approvals from February 2024

Last week, the Food and Drug Administration (FDA) approved four different therapies in the oncology space — one of which, Amtagvi, marks the first cellular therapy for the treatment of solid cancers. ...

23 Feb 20246min

S6 Ep19: Pancreatic Cancer Approval, Expert Discussion on Cancer Vaccine Development

S6 Ep19: Pancreatic Cancer Approval, Expert Discussion on Cancer Vaccine Development

Last week, we saw some FDA approvals for a new drug regimens, as well as some expert opinion about cancer vaccines. Additionally research touched upon the potential benefit of concurrent ctDNA and tum...

19 Feb 20249min

S6 Ep18: Guidelines for Childhood Neuroblastoma, FDA Decisions and More

S6 Ep18: Guidelines for Childhood Neuroblastoma, FDA Decisions and More

Last week, we saw a few moving parts in the regulatory space, from new NCCN guidelines for pediatric neuroblastoma treatment to FDA Fast Tracks and Priority Reviews. Also last week, we covered researc...

12 Feb 20247min

Populært innen Vitenskap

fastlegen
tingenes-tilstand
rekommandert
forskningno
liberal-halvtime
vett-og-vitenskap-med-gaute-einevoll
sinnsyn
jss
rss-paradigmepodden
fjellsportpodden
tomprat-med-gunnar-tjomlid
dekodet-2
rss-inn-til-kjernen-med-sunniva-rose
hva-er-greia-med
rss-rekommandert
rss-zahid-ali-hjelper-deg
nevropodden
kvinnehelsepodden
rss-overskuddsliv
diagnose